Gsk (GSK) Assets Average (2009 - 2026)

Gsk (GSK) has 18 years of Assets Average data on file, last reported at $83.8 billion in Q2 2026.

• For the quarter ending Q2 2026, Assets Average rose 7.77% year-over-year to $83.8 billion; the trailing twelve-month figure through Jun 2026 stood at $83.8 billion (up 7.77% YoY), and the FY2025 full-year result was $78.7 billion, up 5.29% from the prior year.
• Assets Average was $83.8 billion for Q2 2026 at Gsk, up from $83.0 billion in the prior quarter.
• In the past five years, Assets Average ranged from a high of $91.6 billion in Q3 2022 to a low of $70.8 billion in Q4 2022.
• A 5-year average of $78.2 billion and a median of $76.1 billion in 2024 frame the typical range for Assets Average.
• Across the five-year window, Assets Average sank 34.16% in 2022 and advanced 8.81% in 2025, its largest moves.
• Gsk's Assets Average stood at $70.8 billion in 2022, then advanced by 6.14% to $75.2 billion in 2023, then rose by 0.94% to $75.9 billion in 2024, then grew by 8.12% to $82.0 billion in 2025, then increased by 2.15% to $83.8 billion in 2026.
• Per Business Quant data, the three most recent Assets Average figures were $83.8 billion in Q2 2026, $83.0 billion in Q1 2026, and $82.0 billion in Q4 2025.